期刊文献+

血清人软骨糖蛋白39在高血压患者外周血中的表达及意义 被引量:1

The expression and clinical significance of serum cartilage glycoprotein 39 in patients with hypertension
下载PDF
导出
摘要 目的探索血清人软骨糖蛋白39(YKL-40)在高血压外周血中的表达及意义。方法住院接受诊疗的高血压患者列为观察组。另纳入健康体检者作为对照组。本研究共纳入观察组45例,对照组30例。分别检测两组的YKL-40、白介素-6(IL-6)、内皮素-1(ET-1)、C反应蛋白(CRP)等指标。结果观察组患者三酰甘油水平显著高于对照组,差异有统计学意义(t=2.589,P=0.012)。观察组患者外周血ET-1水平显著高于对照组(t=10.900,P<0.01);观察组外周血YKL-40显著高于对照组[(42.96±10.55)μg/L比(28.18±7.25)μg/L;t=6.686,P<0.01];观察组外周血CRP水平显著高于对照组,差异有统计学意义[(6.51±2.16)mg/L比(4.23±1.08)mg/L,t=5.345,P<0.01]。观察组患者血清YKL-40与CRP呈现显著正相关,具有统计学意义(r=0.838,P<0.01);观察组患者血清YKL-40与ET-1呈现显著正相关,差异有统计学意义(r=0.816,P<0.01)。结论高血压患者血清YKL-40升高,且与炎症和代谢紊乱相关,可用以辅助临床诊疗。 Objective To explore the expression and clinical significance of serum cartilage glycoprotein 39 in patients with hypertension. Methods Forty-five patients with hypertension received treatment in our hospital from 2012 to 2015 were collected as observational group. Thirty healthy controls were enrolled as control group. Results The triglyceride, ET-1 and CRP of observational group was higher than those of control group, the difference was statistically significant (t = 2. 589,P =0. 012 ; t = 10. 900, P 〈 0. 01 ; t =5. 345, P 〈 0. 01 ) . Correlation analysis showed the levels ofYKL-40 had significant positive correlation with CRP and ET-1 ( P 〈 0. 01 ) in the observational group. Conclusion The level of YKL-40 increased in patients with hypertension,which may be associated with inflammation and metabolicdisorders.
出处 《中国临床保健杂志》 CAS 2016年第5期478-480,共3页 Chinese Journal of Clinical Healthcare
关键词 高血压 糖蛋白类 危险因素 Hypertension Glycoproteins Risk factors
  • 相关文献

参考文献5

二级参考文献78

  • 1黄炳中,张建.冠心病患者血清C反应蛋白检测及临床分析[J].安徽医药,2004,8(6):449-450. 被引量:3
  • 2赵志宏,隋秀芳,章生龙.彩色多普勒超声对2型糖尿病颈动脉病变的诊断价值[J].中国临床保健杂志,2013,16(6):626-627. 被引量:6
  • 3Mendis S,Ranatunga P.Hypethomocysteinaemia in Sri Lankan patientswith coronary artery disease[J].Ceylon Med J,2002,47(3):89-92.
  • 4Gensini GG..A more meaningful scoring system for deter-mining the severity of coronary heart disease[J].Am J Cardiol,1994,47(1):37-43.
  • 5Wang Y,Ripa RS,Johansen JS,et a1.YKL-40a new bio-marker in patients with acute coronary syndrome or stable coronary artery disease[J].Scand Cardiovasc J,2008,42(5):295-302.
  • 6Wang Y,Ripa RS,Johansen JS,et a1.YKL-40a new bio-marker in patients with acute coronary syndrome or stable coronary artery disease[J].Scand Cardiovasc J.2008,42(5):295-302.
  • 7Zheng JL,Lu L,Hu J,et al.Increased serum YKL-40and C-reactive protein levels are associated with angiographic lesion progression in patients with coronary artery disease[J].Atherosclerosis,2010,210(2):590-595.
  • 8Kahn R,Buse J,Ferrannini E,et al.The metabolic syndrome:time tor a critical appraisal.Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.Diabetologia,2005,48 (9):1684-1699.
  • 9Ford ES,Giles WH.Serum C-reactive protein and fibrinogen concentrations and self-reported angina pectoris and myocardial infarction:findings from National Health and Nutrition Examination Survey Ⅲ.J Clin Epidemiol,2000,53(1):95-102.
  • 10Bermudez EA,Rifai N,Buring J,et al.Inerrelationships among circulating interleukin-6,C-reactive protein,and traditional cardiovascular risk factors in women.Arterioscler Thromb Vasc Bion,2002,22 (10):1668-1673.

共引文献79

同被引文献12

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部